Johnson & Johnson’s COVID-19 vaccine is being paused in America after six women developed rare blood clots, including one who has died and one is in the hospital in a critical condition.
Seven million people in the US have had the one-shot vaccine.
The FDA tweeted yesterday, ‘Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine.
We are recommending a pause in the use of this vaccine out of an abundance of caution.

The rollout of the Johnson & Johnson COVID vaccine across Europe has also been delayed.
The healthcare giant said on Tuesday it had “made the decision to proactively delay the rollout of our vaccine in Europe”.
The symptoms occurred 6 to 13 days after they received the jab.
The US review of the Johnson & Johnson jab comes following the recent concerns over the link between the Oxford-AstraZeneca vaccine and blood clots.
The UK has not approved the Johnson & Johnson vaccine for use, but 30 million doses have been ordered.
Source: Sky News
